Skip to main content
. 2012 Mar 11;3(3):286–298. doi: 10.18632/oncotarget.373

Figure 5. Kaplan-Meier curves showing probability of no recurrence based on combinations of positive- and negative-MMP-9 margins with lymphatic/vascular invasion (LVI) status.

Figure 5

(A, B) MMP-9 positive and MMP-9 negative margin patients without and with LVI, respectively. (C, D) LVI-positive and LVI-negative patients with MMP-9 negative and MMP-9 positive margins, respectively.